Phase
Condition
Hiv
Lung Disease
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pulmonary MDR-TB
Sputum smear and sputum culture positive at baseline
Oral administration of either moxifloxacin or levofloxacin
Written informed consent (for use of the medical data)
Exclusion
Exclusion Criteria:
- Pregnancy or breast feeding
Study Design
Connect with a study center
The Prince Charles and Caboolture Hospitals
Brisbane,
AustraliaSite Not Available
Republican Scientific and Practical Centre of Pulmonology and Tuberculosis
Minsk,
BelarusSite Not Available
Hélio Fraga Reference Center
Rio De Janeiro,
BrazilSite Not Available
Athens Chest Hospital "Sotiria"
Athens,
GreeceActive - Recruiting
Alma Mater Studiorum University of Bologna
Bologna,
ItalySite Not Available
Reuh Tldc
Upeslejas,
LatviaSite Not Available
Instituto Nacional de Enfermedades Respiratorias
Mexico City,
MexicoSite Not Available
University Medical Center Groningen Beatrixoord
Haren,
NetherlandsSite Not Available
Vila Nova Gaia/Espinho Medical School
Vila Nova De Gaia,
PortugalSite Not Available
University of Cape Town, Lung Insitute
Cape Town,
South AfricaSite Not Available
Karolinska University Hospital
Stockholm,
SwedenSite Not Available
Kibong'oto Infectious Diseases Hospital
Sanya Juu,
TanzaniaSite Not Available
Royal London Hospital
London,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.